Functional Inhibition of VEGF and EGFR Suppressors in Cancer Treatment

Curr Top Med Chem. 2019;19(3):178-179. doi: 10.2174/156802661903190328155731.

Authors

Anuraj Nayarisseri¹, Sanjeev Kumar Singh²

Affiliations

¹ Principal Scientist In silico Research Laboratory Eminent Biosciences 91, Sector-A, Mahalakshmi Nagar Indore - 452010, Madhya Pradesh, India.
² Computer Aided Drug Design and Molecular Modelling Lab. Department of Bioinformatics, Alagappa University Karaikudi -630003,Tamil Nadu, India.

PMID: 30950335
DOI: 10.2174/156802661903190328155731

No abstract available

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

MeSH terms

Angiogenesis Inhibitors / pharmacology
Angiogenesis Inhibitors / therapeutic use
Antineoplastic Agents / pharmacology*
Antineoplastic Agents / therapeutic use*
ErbB Receptors / antagonists & inhibitors*
Humans
Neoplasms / drug therapy*
Vascular Endothelial Growth Factor A / antagonists & inhibitors*
Vascular Endothelial Growth Factor Receptor-2 / antagonists & inhibitors

Substances

Angiogenesis Inhibitors
Antineoplastic Agents
Vascular Endothelial Growth Factor A
ErbB Receptors
KDR protein, human
Vascular Endothelial Growth Factor Receptor-2